---
title: ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation
  of p21-activated kinase 1
date: '2023-08-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37537668/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230804180814&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our findings indicated that instead of treatment with Sorafenib
  alone, the combination of ATRA and Sorafenib provides a more effective treatment
  for HCC patients. Video ...'
disable_comments: true
---
CONCLUSIONS: Our findings indicated that instead of treatment with Sorafenib alone, the combination of ATRA and Sorafenib provides a more effective treatment for HCC patients. Video ...